Once again, Apple has taken the top spot this week on TheStreet.com’s list of most-searched stocks. And while Apple’s top spot is pretty definitive, Dan Fitzpatrick explained that the company’s stock chart was less clear. With a series of lower highs in Apple’s share price over the last week, sellers are more eager to take what they can get from the stock right now. Fitzpatrick sees more “sideways trading” than anything else, suggesting that Apple’s overall trend – at least in the short term – is flat.

While everybody’s long GE right now, according to Fitzpatrick, the chart isn’t a pretty sight – GE has managed to more or less track the S&P 500 through the market’s collapse this year. “If you’re long this stock you either know something I don’t know, or you’re just plain hoping,” explained Fitzpatrick. With a downtrending stock price, GE is “generally a bad trade.”

“I see a stock that needs the blue pill that Pfizer makes,” joked Fitzpatrick. Pfizer has been trending lower for around two years now, offering investors a glimmer of hope that the stock’s due for a turnaround. Indeed, PFE saw a distinct bottom just a little while ago, but Fitzpatrick warned not to buy yet. With no evidence of an upcoming breakout, or movement above its price resistance level, he advises waiting until the price crosses short-term resistance and the stock can grow legs.

With a tendency to bounce off its 50-day moving average, the stock’s average price over the trailing 50 days, Starbucks is definitely a stock to watch per Fitzpatrick. He recommended buying with a stop around $9.20 to limit risk to the downside.

With a recent SEC decision that will allow a partner of NYX to act as a counterparty to credit default swaps, things are looking good for the company – and it’s about time. According to Fitzpatrick, NYX “has been in freefall for quite a while.” If you’re into this stock, he advised going to the long side but keeping a tight stop in place.

“This stock has been beaten to a pulp over the last 6 months or so,” said Fitzpatrick. The stock has been pushed down on monstrous volume over the last week or so, with a slight shift upward towards the end of the week, but Fitzpatrick warned against thinking that the stock was on an extended climb – the price increase was on much lower trading volume, suggesting that once the regular sellers come back into play ANF would continue to get pummeled. Watch out for this one.

This stock traded sideways in 2007 and has been on an accelerated downtrend ever since. The 200-day moving average (the average price over the last 200 days) is a good indicator of a stock’s resistance, and SPH has been making a run toward that line, a bullish sign that could point to a breakout. Fitzpatrick recommended keeping a deliberate stop around support, the price SPH has difficulty falling below, in case the downtrend reasserts itself in the future.

Hologic has seen a sharp downtrend recently that could be a bottom, but isn’t necessarily so. Because the bottom in question came without abnormal volume (which would indicate bulls were fighting to keep the stock above that support line), Fitzpatrick wasn’t so sure. If you’re taking a long position in HOLX, be careful.